Who owns KALA PHARMACEUTICALS INC?
- CUSIP Number: 483119202
Tip: Access positions for across all investors
Analyze quarterly positions in Kala Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Kala Pharmaceuticals stock
Who bought or sold KALA PHARMACEUTICALS INC this quarter?
There are no current stakeholders of Kala Pharmaceuticals.
This is normal when the security:
- Has been acquired or taken private
- Has merged with another entity
- Has changed its name and has a new CUSIP (and/or symbol)
- Has been delisted and the ticker has changed
Please use Search to find the security you were looking for.
Who sold out of Kala Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Renaissance Technologies | Mar 2026 | 418k | $72k |
| Citadel Advisors | Mar 2026 | 282k | $49k |
| Geode Capital Management | Mar 2026 | 261k | $45k |
| Virtu Financial | Mar 2026 | 152k | $26k |
| ADAR1 Capital Management | Mar 2026 | 142k | $25k |
| GSA Capital Partners | Mar 2026 | 85k | $15k |
| UBS Group | Mar 2026 | 67k | $12k |
| Vanguard Capital Management | Mar 2026 | 61k | $11k |
| Jane Street | Mar 2026 | 36k | $6.2k |
| Vanguard Fiduciary Trust | Mar 2026 | 30k | $5.1k |
| State Street Corporation | Mar 2026 | 29k | $4.9k |
| Greenwich Wealth Management | Mar 2026 | 18k | $3.0k |
| LPL Financial | Mar 2026 | 17k | $3.0k |
| Goldman Sachs Group | Mar 2026 | 14k | $2.4k |
| Intl Fcstone | Mar 2026 | 13k | $2.2k |
| Northern Trust | Mar 2026 | 12k | $2.0k |
| BlackRock | Mar 2026 | 11k | $1.9k |